News

You are here:-News

Vaping Related Illnesses Named EVALI

The CDC names a rapidly growing illness in the U.S. As of October 21, 2019, there have been over 1,500 cases vaping related illnesses reported in 49 states, along with 33 deaths. Awareness of lung problems associated with vaping became widely known when several stories went viral on social media, including one of a 17-year-old

By |2019-10-27T14:35:44+00:00October 27th, 2019|Categories: News|Tags: , , |0 Comments

Gut Microbiome Study Could Help Educate Influence on Immune System

Collaboration with Quadram Institute Bioscience Will Focus on New Therapies for Immune-Related Conditions DuPont Nutrition and Biosciences announced a 3-year project to study gut bacteria's influence the immune system. The company is partnering with Quadram Institute Bioscience (QIB) to complete the focus. The research will evaluate how extracellular vesicles (EVs), which are naturally produced by the

By |2019-09-30T22:12:41+00:00September 30th, 2019|Categories: Microbiome, News|Tags: , |0 Comments

Lolo Jones and Kerri Walsh Jennings Partner With cbdMD

CHARLOTTE, N.C. (PRWEB) JULY 12, 2019 cbdMD, Inc., a nationally recognized consumer cannabidiol (CBD) brand (NYSE American: YCBD), has just announced that Olympians Lolo Jones and Kerri Walsh Jennings have officially joined Team cbdMD. The partnerships will offer a massive platform for cbdMD to provide CBD education and brand awareness to athletes, fans, and consumers around

By |2019-07-15T15:37:37+00:00July 15th, 2019|Categories: News|Tags: , , |0 Comments

Multiple Myeloma Treatment Drug Submitted to FDA

Janssen ( a Johnson and Johnson Company) Submits Application to U.S. FDA Seeking Approval of New DARZALEX® (daratumumab) Subcutaneous Formulation, Innovative Treatment for Multiple Myeloma RARITAN, N.J., July 12, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration

By |2019-07-15T12:52:28+00:00July 15th, 2019|Categories: News|Tags: , |0 Comments

Next Generation Precision Oncology and Infectious Disease To Be Discussed At Basel Computational Biology Conference In Switzerland

  Join the international [BC]2 conference and EMBO meeting at BASEL LIFE from 9–12 September: a unique opportunity for today’s scientists to get insights and share the latest discoveries, resources and approaches to make sense of genomic and health-related “big data” for molecular medicine – from precision oncology to infectious diseases. Advances in next generation

By |2019-07-13T13:23:44+00:00July 10th, 2019|Categories: Infectious Disease, News, Oncology|Tags: , |0 Comments

Modere’s Logiq™ with TetraBlend™ Coffee Wins 2019 Beauty Shortlist Award

Beauty and brain-boosting, collagen-enhanced coffee blend named “Best Health Drink” by leading natural beauty blog awards Modere’s new cognitive-enhancing collagen and hyaluronic acid-based proprietary coffee blend, Modere Logiq™ with TetraBlend™ Coffee, has won the prestigious 2019 Beauty Shortlist Mama & Baby Award for “Best Health Drink” in the awards’ wellbeing category. Modere Logiq™ with TetraBlend™

By |2019-07-15T15:07:07+00:00June 24th, 2019|Categories: News|Tags: , , |0 Comments

Skinuva™ Scar Launches Next-Generation Scar Cream

Skinuva™ Scar, Founded By Beverly Hills Based Dr. Christopher Zoumalan, is a next-generation new scar cream that is the first to use highly selective growth factors in its unique formulation. Skinuva™ Scar is a next-generation new scar cream that is the first of its kind to use highly selective growth factors in its unique formulation.

By |2019-07-15T15:06:30+00:00June 20th, 2019|Categories: News|Tags: |0 Comments

Skin Microbiome Startup DermBiont Raises $8M Series A to Treat the Root Cause of Skin Diseases

DermBiont, a clinical stage therapeutics company dedicated to the discovery and development of live bacterial products for the treatment of skin diseases has closed an $8M Series A. The funding round was led by Zola Global Investors, Toba Capital, and Viking Global Investors. The financing proceeds will be used to fund ongoing clinical trials and

By |2019-06-25T15:10:12+00:00June 18th, 2019|Categories: News|Tags: , |0 Comments

3 Things to Consider When Setting Summer Fitness Goals

Working out more often and other fitness-related goals are the most common New Year’s resolution, but it can be difficult to make time and find motivation for exercise during the winter. If you didn’t gain the momentum you wanted over the winter, that doesn’t mean it’s too late to get started now. While many people

By |2019-07-15T15:16:18+00:00May 15th, 2019|Categories: Beauty, News|0 Comments

Is Your Doctor Risking Your Health?

Why a doctor's white coat could be contributing to the spread of harmful bacteria The honorary white coat most doctors wear is a symbol of their profession, showcasing their doctorness and clout. Patients actually prefer their doctors to dress in a white coat, perhaps because it helps the professional stand out in appearance alone. (We

By |2019-05-09T11:08:31+00:00May 9th, 2019|Categories: News|Tags: , , |0 Comments